Huo Zhang

PR China
Nanjing, Puerto Rico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.

MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.

Journal: Gene
Published: June 09, 2019

Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.

Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.

Journal: Cancer medicine
Published: June 09, 2019

A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.

A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.

Journal: Gene
Published: August 06, 2018

A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.

A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.

Journal: Gene
Published: June 19, 2018

Differential expression levels of plasma microRNA in Hashimoto's disease.

Differential expression levels of plasma microRNA in Hashimoto's disease.

Journal: Gene
Published: August 08, 2017

Plasma microRNA signature of patients with IgA nephropathy.

Plasma microRNA signature of patients with IgA nephropathy.

Journal: Gene
Published: July 23, 2017

A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.

A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.

Journal: Oncotarget
Published: December 21, 2016

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

Journal: Oncotarget
Published: October 25, 2016

miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.

miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.

Journal: PloS one
Published: August 24, 2016

Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.

Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.

Journal: Oncotarget
Published: July 18, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026